Vanessa Rodriguez
Endocrinology, Diabetes & Metabolism · Delray Beach, FLNPI 1427017441
Payments from drug & device makers
Across 137 payments — averaging $19.29 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- Novo Nordisk$589
- Amgen$291
- AstraZeneca$250
- Lilly USA, LLC$144
- Medtronic$128
- Johnson & Johnson$113
- plus $1K from 24 others
What the payments were for
- Food & beverage$2,635100%
- Education$80%
Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| Novo Nordisk | 34 | $589 |
| Amgen | 11 | $291 |
| AstraZeneca | 12 | $250 |
| Lilly USA, LLC | 12 | $144 |
| Medtronic(2 entities) | 6 | $128 |
| Johnson & Johnson | 6 | $113 |
| Edwards Lifesciences | 1 | $100 |
| Sanofi-aventis U.S. LLC | 5 | $90 |
| Mannkind Corporation | 4 | $88 |
| AbbVie | 5 | $85 |
| Boehringer Ingelheim | 3 | $81 |
| Merck | 6 | $80 |
| Dexcom, Inc. | 3 | $60 |
| BD | 2 | $56 |
| Valeritas, Inc. | 2 | $49 |
| Amarin Pharma, Inc. | 3 | $47 |
| Radius Health, Inc. | 3 | $47 |
| Shire North American Group Inc | 2 | $44 |
| Sequel Med Tech, LLC | 2 | $43 |
| Amneal Pharmaceuticals LLC | 3 | $42 |
| Ascendis Pharma Endocrinology Inc | 2 | $39 |
| Recordati_rare_diseases_inc. | 2 | $35 |
| UCB, Inc. | 1 | $29 |
| Regeneron Healthcare Solutions, Inc. | 1 | $22 |
| Corcept Therapeutics | 1 | $20 |
| IBSA Pharma Inc. | 1 | $17 |
| Vivus LLC | 1 | $15 |
| Senseonics, Incorporated | 1 | $13 |
| Abbott | 1 | $13 |
| EUSA Pharma (US) LLC | 1 | $13 |
What the payments were tied to
Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.
How this compares
$2,643 in reported general payments places this provider in the 40th percentile of 586 endocrinology, diabetes & metabolism providers in Florida.
See all endocrinology, diabetes & metabolism providers in Florida →
Most prescribed under Part D
| Drug | Claims | Cost to plans & patients |
|---|---|---|
| MounjaroTirzepatide | 66 | $83,403 |
| OzempicSemaglutide | 19 | $29,436 |
| JardianceEmpagliflozin | 14 | $23,472 |
| Omnipod 5 Dexg7g6 Pods (Gen 5)Insulin Pump Cart,auto,bt,g6/7 | 24 | $20,786 |
| Tresiba Flextouch U-200Insulin Degludec | 11 | $14,371 |
| Tresiba Flextouch U-100Insulin Degludec | 13 | $8,471 |
| SynthroidLevothyroxine Sodium | 29 | $3,640 |
| LevoxylLevothyroxine Sodium | 17 | $464 |
| Ezetimibe | 15 | $462 |
| Metformin Hcl ErMetformin Hcl | 37 | $385 |
| Rosuvastatin Calcium | 18 | $262 |
| Alendronate Sodium | 11 | $184 |
| Atorvastatin Calcium | 17 | $81 |
| UnithroidLevothyroxine Sodium | 12 | $52 |
Paid to pharmacies, not to this prescriber.
Companies that both paid and supply prescribed drugs
These companies both reported payments to this provider and make drugs the provider prescribed under Medicare Part D in 2024. For most specialties this overlap is expected — a cardiologist who is paid by a cardiology drugmaker also treats heart disease. It is shown so the reader can see it, not because it implies anything on its own.
| Company | Paid to this provider | Part D cost of their drugs |
|---|---|---|
| Lilly USA, LLCMounjaro | $144 | $83,40366 claims |
| Novo NordiskOzempic | $589 | $29,43619 claims |
| Boehringer IngelheimJardiance | $81 | $23,47214 claims |
| AbbVieSynthroid | $85 | $3,64029 claims |
| Amneal Pharmaceuticals LLCUnithroid | $42 | $5212 claims |
Reading this fairly. The Part D column is what drug plans and patients paid pharmacies — this provider received none of it, and it reflects how many patients they treat and what those drugs cost. Against peers, this provider's reported payments sit in the 40th percentile of 586 endocrinology, diabetes & metabolism providers in Florida.
Other endocrinology, diabetes & metabolism in Delray Beach
- Richard PratleyOrlando$9.2M
- Jose MandryOcoee$9.1M
- Steven SmithOrlando$7.9M
- Barry HorowitzWest Palm Beach$7.1M
- Tina ThethiOrlando$3.8M
- David SuttonJacksonville$3.1M
- Lorena Lewy-AlterbaumHollywood$3.1M
- Mae Sheikh AliJacksonville$2.9M
- James MageeJacksonville$2.7M
- Rodolfo GalindoMiami$2.5M
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Identity: NPPES NPI Registry, July 2026.